In a precedential decision issued May 6, 2025, the Federal Circuit reversed in part and vacated in part a Delaware district ...

Cir. Mar. 21, 2025) marked a victory for generic drug developers, affirming that legal expenses incurred defending Hatch-Waxman suits are tax-deductible as ordinary and necessary business expenses.